News

BioM's articles about and for the Bavarian biotechnology sector


m4 Award 2019: 2.5 million euros for the fight against cancer and antibiotic resistance

Bav­aria sets im­pulses for the medi­cine of the fu­tureThe pre-seed com­pet­i­tion m4 Award an­nounces win­ners m4 Award win­ners…

Successful workshop on how to enter the challenging Japanese life science market

Ten European SMEs trav­elled to BioM in Martin­sried, to take part in an in­tens­ive 4-day Japan work­shop from 9-12 Septem­ber cov­er­ing…

Immatics seals million-dollar deal with Celgene

Im­mat­ics enters into a stra­tegic col­lab­or­a­tion with Cel­gene to de­vel­op novel can­cer cell ther­apies. The Ger­man bi­otech…

Munich VC Wellington raises €210M fund to back European biotechs

210 Mio € statt der ei­gent­lich er­war­teten 120-150 Mio € waren in­sti­tu­tion­elle In­vestoren, Fam­ily Of­fices und Priv­at­in­vestoren…

TUM and LMU awarded as University of Excellence

The Ex­cel­lence Com­mis­sion con­sist­ing of 39 in­ter­na­tion­al ex­perts and the fed­er­al min­is­ters has se­lec­ted 10 uni­ver­sit­ies…

From an idea to a validated concept

On July 12, the final of the "EIT Health BioEn­tre­pren­eur­ship Lab Ox­ford-Mu­nich 2019" took place at BioMM in Martin­sried near Mu­nich…

European companies selected under EIT Health Go Global Program to reach Japanese and Korean

Fol­low­ing an in­tens­ive se­lec­tion pro­cess through a ded­ic­ated sec­tor-spe­cif­ic jury, el­ev­en European com­pan­ies are laur­eates…

FORUM Science & Health provides new impulses for personalized medicine

On July 3/4, the 2nd FORUM Science & Health took place in Für­sten­feld­bruck near Mu­nich. The suc­cess­ful event brought to­geth­er more…

BioM is partner in the new Peer2scale project

Peer­2s­cale, an HORIZON 2020 pro­ject, is a peer-learn­ing ac­tion between four re­gion­al health agen­cies act­ing as clusters.…

Kress becomes new CEO of MorphoSys

The Su­per­vis­ory Board of MorphoSys AG has today ap­poin­ted Dr. Jean-Paul Kress as its new CEO. The ap­point­ment will take ef­fect on…

Newsletter

Subscribe

Archive



Publish press release

Would you like to enter or update data?
Request login data


Dr. Georg Kääb
Dr. Georg Kääb

Corporate Communications, Managing Director Bavarian Biotech Cluster